1.Peroneal Artery Bypass Grafting through a Median Approach in Two Cases of Thromboangitis Obliterans.
Kenji Okada ; Nobuhiko Mukohara ; Kyoichi Ogawa ; Tatsuro Asada ; Masami Nishiwaki ; Tetsuya Higami ; Takaki Sugimoto ; Tsuyoshi Kawamura
Japanese Journal of Cardiovascular Surgery 1994;23(2):122-124
In two cases of thromboangitis obliterans (TAO) a popliteal-posterior tibial-peroneal artery sequential bypass was attempted through a median approach. The 1st case underwent the operation successfully with non-reversed saphenous vein graft. However, only popliteal-peroneal bypass was carried out in the 2nd patient because the posterior tibial artery was severely affected. In surgery of TAO patients, careful assessment of preoperative angiographic findings is important to select the site of distal anastomosis. We found that the posterior tibial artery and the peroneal artery are easily accessible through the medial route in the proximal half of the lower leg and that peroneal artery revascularization was effective for limb salvage.
2.Assessment of Cardiac Function Using Echocardiography in Long-Term Hemodialysis Patients.
Takeshi ISHIYAMA ; Yoshiaki MIURA ; Masami OKADA ; Tsukasa NAKAMARU ; Yoshifumi ASANO ; Hitoshi MURAYAMA ; Wataru SASAKI
Journal of the Japanese Association of Rural Medicine 1995;44(1):27-31
Echocardiography was performed in two gruops of patients with impaired renal function excluding those with diabetic renal failure. Group A was comprised of 19 patients who had recieved hemodialysis from 1 year to 5 years, and Group B, of 32 patients who had been undergoing hemodialysis for more than 10 years. Significant reductions in left ventricular diastolic dimensions and cardiac output were found in Group B. In these two groups, there were no statistically significant differences in left ventricular wall thickness and left ventricular ejection fraction. Left ventricular diastolic function was assessd by the ratio of the peak atrial velosity (A) to early diastolic velosity (E). 15 patients (83%) in Group A and 19 patients (76%) in Group B had left ventricular diastolic dysfunction. A high incidence of left ventricular diastolic dysfunction was revealed. Moreover, dilated and hypertrophic cardiomyopathy like patterns were observed in both groups. In Group B, significantly increased left ventricular wall thickness in patients with hypertension and reduced left ventricular systolic function in patients with dialysis hypotension were found.
3.Surgery of Descending Thoracic Aortic Aneurysms with Use of a Centrifugal Pump. Usefulness of the Autotransfusion System.
Nobuhiko MUKOHARA ; Kyoichi OGAWA ; Tatsuro ASADA ; Masami NISHIWAKI ; Tetsuya HIGAMI ; Takaki SUGIMOTO ; Kenji OKADA ; Tsuyoshi KAWAMURA ; Mikio CHIBANA
Japanese Journal of Cardiovascular Surgery 1993;22(2):103-106
We reviewed the results of 14 patients who underwent the operation of thoracic aneurysms using a centrifugal pump. Nine patients had atherosclerotic aneurysms and 5 had aortic dissections. The autotransfusion system (ATS) was used to keep hemodynamic stability by rapid transfusion. The ATS consisted of a roller pump, a 2, 000ml reservoir and a heat exchanger. Two mg/kg of heparin was given to the patients to keep ACT over 400 seconds. All patients survived. Body temperature increased 0.08±0.59°C during bypass with the ATS, and no patients showed hemodynamic instability after aneurysmotomy under the help of the ATS. We conclude that 1) the centrifugal pump is a useful and safe assisting means for the surgery of thoracic aneurysms, 2) the autotransfusion system has advantages as follows: keeping stable circulation and preventing loss of body temperature during bypass.
4.Identification and International Comparison of Drugs Contraindicated for Pregnant Women in the Package Inserts
Takamasa SAKAI ; Yuri SATO ; Shiro HATAKEYAMA ; Daisuke KIKUCHI ; Masami TSUCHIYA ; Yuki KONDO ; Izumi SATO ; Yuko OKADA ; Taku OBARA
Japanese Journal of Drug Informatics 2024;25(4):211-219
Objective: The package inserts are official clinical decision-making documents that provide pharmacological treatment information. However, it has been noted that package inserts on perinatal drug usage differ greatly from expert opinions. This study identified Japanese package insert drugs that are contraindicated for pregnant women and compared them to foreign risk categories.Methods: The survey included 19,022 drugs on the drug pricing list as of April 2022, with package inserts available on the Pharmaceuticals and Medical Devices Agency website. We retrieved the package inserts with the word “pregnant” in the “Contraindications” section and reviewed the descriptions to exclude those that satisfied the exclusion criteria. We also checked the foreign risk categories of contraindicated ingredients for pregnant women. This study used the Australian Therapeutic Goods Administration’s categorization for prescribing medicines in pregnancy (the TGA classification).Results: Of the 19,022 medicines studied, 4,111 (21.6%) were contraindicated for pregnant women. Conversely, 19 (5.1%) ingredients categorized under the relatively safe TGA classifications A, B1, and B2 were also contraindicated for pregnant Japanese women.Conclusion: This study revealed that Japanese package inserts contraindicate over 20% of drugs for pregnant women. On the other hand, some forbidden ingredients did not match the foreign risk categories. Therefore, healthcare professionals should be aware of the limitations of Japanese package inserts concerning pregnant women and make careful decisions based on both package inserts and additional drug information.